Reference record
Study of Myo/Pericarditis Associated With COMIRNATY (Vaccine to Prevent COVID-19) in Persons <21 Years of Age
NCT05295290
First Published (first received 2022 March 25)https://clinicaltrials.gov/show/NCT05295290 (https://clinicaltrials.gov/show/NCT05295290)
Trial registry recordNo Results
The primary aim of this low interventional cohort study is to characterize the potential
long-term sequelae associated with myocarditis/pericarditis following vaccination with
COMIRNATY, compared with associated myocarditis/pericarditis following COVID-19 in persons
<21 years old, with up to 5 years of follow-up